Tran, Kim TuMcMenamin, Úna C.Coleman, Helen G.Cardwell, Chris R.Murchie, PeterIversen, LisaLee, Amanda J.Thrift, Aaron P.2020-06-032020-06-032020-03-01Tran, K T, McMenamin, Ú C, Coleman, H G, Cardwell, C R, Murchie, P, Iversen, L, Lee, A J & Thrift, A P 2020, 'Statin use and risk of liver cancer : Evidence from two population-based studies', International Journal of Cancer, vol. 146, no. 5, pp. 1250-1260. https://doi.org/10.1002/ijc.324260020-7136Mendeley: 74120b74-bcb3-3bf9-a531-94507acb180dORCID: /0000-0001-9968-5991/work/83704237ORCID: /0000-0002-4865-9061/work/159078231https://hdl.handle.net/2164/14433The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number 34374. We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting our study. KTT is supported by the Vietnam International Education Cooperation Department. Access to PCCIU data was provided by Queen's University Belfast and the Centre for Academic Primary Care, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM.11195393engSDG 3 - Good Health and Well-beingstatinsliver cancerhepatocellular carcinomaintrahepatic bile duct carcinomaRC0254 Neoplasms. Tumors. Oncology (including Cancer)OncologyCancer ResearchCancer Research UKRC0254Journal article10.1002/ijc.32426http://www.mendeley.com/research/statin-risk-liver-cancer-evidence-two-populationbased-studieshttp://www.scopus.com/inward/record.url?scp=85067011209&partnerID=8YFLogxK1465